The Neurotrophin Neuritin1 (cpg15) is involved in melanoma migration, attachment independent growth, and vascular mimicry.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27901477)

Published in Oncotarget on November 25, 2016

Authors

Anja Katrin Bosserhoff1, Nadja Schneider1, Lisa Ellmann2, Lucie Heinzerling3, Silke Kuphal1

Author Affiliations

1: Institute of Biochemistry (Emil-Fischer-Center), Friedrich Alexander University Erlangen-Nürnberg, Erlangen, 91054, Germany.
2: Institute for Functional Genomics, University Regensburg, Regensburg, 93053, Germany.
3: Institute of Dermatology, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nürnberg, Erlangen, 91054, Germany.

Articles cited by this

Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol (2009) 23.08

Distinct sets of genetic alterations in melanoma. N Engl J Med (2005) 17.26

Clonogenic assay of cells in vitro. Nat Protoc (2006) 11.85

Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine (2000) 2.25

Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res (2011) 2.08

Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application. Cancer (1982) 1.68

BioProfiling.de: analytical web portal for high-throughput cell biology. Nucleic Acids Res (2011) 1.60

The function of activity-regulated genes in the nervous system. Physiol Rev (2009) 1.54

S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma. J Clin Oncol (1999) 1.49

Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus. Cancer Res (2005) 1.48

Promotion of dendritic growth by CPG15, an activity-induced signaling molecule. Science (1998) 1.43

In-depth characterization of microRNA transcriptome in melanoma. PLoS One (2013) 1.38

Characterization of the expression of the hypoxia-induced genes neuritin, TXNIP and IGFBP3 in cancer. FEBS Lett (2006) 1.30

Neurotrophins and their receptors stimulate melanoma cell proliferation and migration. J Invest Dermatol (2008) 1.29

PPISURV: a novel bioinformatics tool for uncovering the hidden role of specific genes in cancer survival outcome. Oncogene (2013) 1.21

Neurotrophin-induced melanoma cell migration is mediated through the actin-bundling protein fascin. Oncogene (2003) 1.17

Activity-regulated genes as mediators of neural circuit plasticity. Prog Neurobiol (2011) 1.13

Tissue microarrays for miniaturized high-throughput molecular profiling of tumors. Exp Hematol (2002) 1.11

Soluble CPG15 expressed during early development rescues cortical progenitors from apoptosis. Nat Neurosci (2005) 1.09

Constitutive HIF-1 activity in malignant melanoma. Eur J Cancer (2010) 0.99

Interim analysis of toxicity and response in phase 1 trial of systemic targeted alpha therapy for metastatic melanoma. Cancer Biol Ther (2007) 0.98

Expression profiling identifies genes involved in emphysema severity. Respir Res (2009) 0.98

Neurotrophins in skin biology and pathology. J Invest Dermatol (2006) 0.97

CPG15 regulates synapse stability in the developing and adult brain. Genes Dev (2011) 0.97

p75 neurotrophin receptor mediates apoptosis in transit-amplifying cells and its overexpression restores cell death in psoriatic keratinocytes. Cell Death Differ (2010) 0.94

The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes. J Clin Invest (1994) 0.94

Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients. Cancer (2003) 0.92

p75 neurotrophin receptor functions as a survival receptor in brain-metastatic melanoma cells. J Cell Biochem (2004) 0.91

MiR-204 promotes apoptosis in oxidative stress-induced rat Schwann cells by suppressing neuritin expression. FEBS Lett (2014) 0.86

Neuritin expression and its relation with proliferation, apoptosis, and angiogenesis in human astrocytoma. Med Oncol (2010) 0.86

Evaluation of multiple serum markers in advanced melanoma. Tumour Biol (2011) 0.86

Characterization of neuritin as a novel angiogenic factor. Biochem Biophys Res Commun (2011) 0.86

CD271 is an imperfect marker for melanoma initiating cells. Oncotarget (2014) 0.86

Expression of neuritin during liver maturation and regeneration. FEBS Lett (2005) 0.83

Human melanoma cell invasion: selected neurotrophin enhancement of invasion and heparanase activity. J Investig Dermatol Symp Proc (1997) 0.82

Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations. Adv Enzyme Regul (1997) 0.81

Differential methylation hybridization profiling identifies involvement of STAT1-mediated pathways in breast cancer. Int J Oncol (2011) 0.80

Comparison of S100 protein and MIA protein as serum marker for malignant melanoma. Anticancer Res (2000) 0.80

Melanoma inhibitory activity in melanoma diagnostics and therapy - a small protein is looming large. Exp Dermatol (2014) 0.78